Clinical Trials Directory

Trials / Completed

CompletedNCT03669796

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I

A Study of the Effects of Marine Protein Hydrolysate as Dietary Supplement on the Regulation of Postprandial Blood Glucose Metabolism in Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Helse Møre og Romsdal HF · Other Government
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the potential effect of a marine protein hydrolysate (MPH) supplement before a meal on postprandial glucose tolerance in healthy subjects, to achieve more knowledge on this presumed beneficial, blood glucose lowering effect

Detailed description

To further investigate the effects of MPH in a single dose of 20 mg/kg of body weight on postprandial blood glucose, insulin and GLP-1 (as markers of glucose metabolism) in healthy, active middle-aged to elderly subjects - age 40-65 years.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMarine protein hydrolysate (mph)Marine (Cod) protein hydrolysate
DIETARY_SUPPLEMENTControlMaltodextrin/Casein

Timeline

Start date
2017-11-27
Primary completion
2018-02-28
Completion
2018-02-28
First posted
2018-09-13
Last updated
2019-11-14

Locations

2 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT03669796. Inclusion in this directory is not an endorsement.

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I (NCT03669796) · Clinical Trials Directory